Delivery Order SPE2DB22D3301-SPE2DB24FZ2BR
Award Date
8/2/24
Potential Completion Date
8/23/24
Potential Value
$7.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,085.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VEKLURY 100 MG VIALS. The contract has a completion date of September 5, 2024 and was awarded on August 14, 2024. This order is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of...
This federal contract award, valued at $4,754.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VEKLURY 100 MG VIALS, a pharmaceutical product, with a performance period extending through March 6, 2025. The contract is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,848.80, is for the procurement of VEKLURY 100 MG VIALS, a medication used for the treatment of COVID-19. The contract has a Firm Fixed Price pricing type and an ultimate completion date of March 25, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp...
This is a $4,085.52 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the supply of VEKLURY 100 MG VIALS, a pharmaceutical product, to support military treatment programs and facilities. The contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has extensive experience...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,085.52 Firm Fixed Price Delivery Order is for the supply of VEKLURY 100 mg vials, a prescription medication used to treat COVID-19. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $27,236.80, is for the supply of VEKLURY 100 mg vials, a critical pharmaceutical product. This order is placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to...
This federal contract award, valued at $13,618.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of VEKLURY 100 MG VIALS. The contract is a delivery order with a firm fixed-price pricing structure and an ultimate completion date of August 19, 2024. Amerisourcebergen, through its Corporate Office Division, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by various...
This federal contract award, valued at $1,584.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VEKLURY 100 MG VIALS, a pharmaceutical product, with a period of performance through April 3, 2025. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
This federal contract award, awarded by the Defense Logistics Agency (DLA), is a delivery order to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of VEKLURY 100 MG VIALS, a pharmaceutical product, with a ceiling value of $13,618.40 and a completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $6,809.20 contract is for the delivery of VEKLURY 100 MG VIALS, a pharmaceutical product, with a completion date of February 8, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related...